TY - JOUR AU - Lopez-Cano, Carolina AU - Ciudin, Andreea AU - Sanchez, Enric AU - Tinahones, Francisco J AU - Barbe, Ferran AU - Dalmases, Mireia AU - Garcia-Ramirez, Marta AU - Soto, Alfonso AU - Gaeta, Anna Michela AU - Pellitero, Silvia AU - Marti, Raquel AU - Hernandez, Cristina AU - Simo, Rafael AU - Lecube, Albert PY - 2022 DO - 10.2337/db21-0688 UR - http://hdl.handle.net/10668/20499 T2 - Diabetes AB - To evaluate the effect of liraglutide, a glucagon-like peptide 1 receptor agonist, on pulmonary function and serum levels of surfactant protein D (SP-D) in type 2 diabetes. A double-blind, randomized, crossover, placebo-controlled clinical trial... LA - en PB - American Diabetes Association KW - Aged KW - Blood Glucose KW - Cross-Over Studies KW - Diabetes Mellitus, Type 2 KW - Double-Blind Method KW - Female KW - Glycemic Control KW - Humans KW - Liraglutide KW - Lung KW - Male KW - Middle Aged KW - Pulmonary Surfactant-Associated Protein D KW - Spain KW - Vital Capacity KW - Liraglutide KW - Pulmonary Surfactant-Associated Protein D KW - Diabetes Mellitus, Type 2 KW - Forced Expiratory Volume KW - Vital Capacity TI - Liraglutide Improves Forced Vital Capacity in Individuals With Type 2 Diabetes: Data From the Randomized Crossover LIRALUNG Study. TY - research article VL - 71 ER -